DBL EPHEDRINE SULFATE INJECTION 30 mgml

국가: 싱가포르

언어: 영어

출처: HSA (Health Sciences Authority)

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
15-01-2020

유효 성분:

EPHEDRINE SULFATE

제공처:

PFIZER PRIVATE LIMITED

ATC 코드:

R03CA02

복용량:

30 mg/ml

약제 형태:

INJECTION

구성:

EPHEDRINE SULFATE 30 mg/ml

관리 경로:

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

처방전 유형:

Prescription Only

Manufactured by:

Siegfried Hameln GmbH

승인 상태:

ACTIVE

승인 날짜:

1989-05-06

제품 특성 요약

                                DBL
™ EPHEDRINE SULFATE INJECTION
NAME OF THE MEDICINE
Ephedrine sulfate USP
The molecular formula of Ephedrine Sulfate is (C
10
H
15
NO)
2
H
2
SO
4
. Its molecular weight is
428.5. The CAS registry number of Ephedrine Sulfate is 134-72-5.
DESCRIPTION
DBL
™
Ephedrine Sulfate Injection is a sterile solution of Ephedrine Sulfate
in Water for
Injections. Each mL contains 30 mg of Ephedrine Sulfate and 3 mg of
Sodium Chloride in
Water for Injections.
PHARMACOLOGY
Ephedrine is a sympathomimetic which stimulates both alpha and beta
adrenergic receptors,
and also releases noradrenaline from storage site. The main effects of
therapeutic doses of
ephedrine are relaxation of bronchial smooth muscle, cardiac
stimulation and increased
systolic and usually diastolic blood pressure via an increase in
cardiac output and peripheral
vasoconstriction. Ephedrine also decreases intestinal tone and
motility, relaxes the bladder
wall, contracts the sphincter muscle, relaxes the detrusor muscle, and
decreases uterine
activity. Ephedrine also has central nervous system stimulant effects.
Tachyphylaxis to the
effects of ephedrine may also occur after use for a short while
possibly due to the depletion of
noradrenaline stores.
PHARMACOKINETICS
Ephedrine is rapidly absorbed after intramuscular or subcutaneous
administration. The onset
of action after intramuscular administration is 10 to 20 minutes, and
the duration of pressor
and cardiac responses to ephedrine is 1 hour after intravenous
administration of 10 to 25 mg
or
intramuscular
or
subcutaneous
administration
of
25
to
50
mg.
Small
quantities
of
ephedrine are metabolised in the liver, but the majority of ephedrine
is excreted unchanged in
the urine. The plasma half-life of ephedrine is 3 to 6 hours.
Elimination of ephedrine is
increased (and hence the half-life is decreased) with decreasing pH of
the urine. Ephedrine is
presumed to cross the placenta, and to be excreted into breast milk.
INDICATIONS
DBL
™
Ephedrine Sulfate Injection is indicated in the treatment of shock
unrespo
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림